Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Q Biomed Inc. (QBIO : OTC)

• Company Description    Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 22,940 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 2.19 52 Week High: $0.03 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 366 MADISON AVENUE 3RD FLOOR - NEW YORK,NY 10017 USA ph: 212-588-0022 fax: - None http://www.qbiomed.com

• General Corporate Information    Officers Denis Corin - Chief Executive Officer; President and Director William Rosenstadt - Chief Legal Officer and Director Rick Panicucci - Director - - - - - - Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 74736N105 SIC: 2834 Fiscal Year Fiscal Year End: November Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 2.19 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 05/31/25 - - 02/28/25 - - 11/30/24 - - ROA 05/31/25 - - 02/28/25 - - 11/30/24 - - Current Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Quick Ratio 05/31/25 - - 02/28/25 - - 11/30/24 - - Operating Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Net Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Pre-Tax Margin 05/31/25 - - 02/28/25 - - 11/30/24 - - Book Value 05/31/25 - - 02/28/25 - - 11/30/24 - - Inventory Turnover 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Equity 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Capital 05/31/25 - - 02/28/25 - - 11/30/24 - -

Powered by Zacks Investment Research ©